This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research Article
Anil Kumar S
Department of Biotechnology, Vignan’s Foundation for Science, Technology & Research
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Declarations:
Declarations
- The author has confirmed that a statement listing potential conflicts of interest or lack thereof is included in the text.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease
2019 (COVID-19). SARS-CoV-2 is known for its high pathogenicity and transmission due to the
presence of polybasic cleavage sites. No specific drug is available for the treatment. To identify
the potential inhibitors, we have performed molecular docking against the SARS-CoV-2 main
protease (6Y84) with fifteen important natural xanthone compounds. The docking results showed
all the compounds exhibited good binding energies and interactions with the main protease. The
validation of representative docking complexes through molecular dynamics simulations showed
that xanthones binds with a higher binding affinity and lower free energy than the standard
ligand with Brasixanthone C and Brasixanthone B on 50 ns. Natural xanthone compounds have
also passed the Absorption, Distribution, Metabolism, and Excretion (ADME) property criteria
as well as Lipinski’s rule of five. The present integrated molecular docking and dynamics
simulations study unveil the use of xanthones as potential antiviral agents against SARS-CoV-2.
Keywords
Antiviral compounds, Covid19, Main protease, Molecular docking, Molecular simulations, Xanthones
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 2
Posted 10 Feb, 2021
No community comments so far
No comments provided
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research Article
Anil Kumar S
Department of Biotechnology, Vignan’s Foundation for Science, Technology & Research
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 2
Posted 10 Feb, 2021
No community comments so far
No comments provided
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Declarations:
Declarations
- The author has confirmed that a statement listing potential conflicts of interest or lack thereof is included in the text.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease
2019 (COVID-19). SARS-CoV-2 is known for its high pathogenicity and transmission due to the
presence of polybasic cleavage sites. No specific drug is available for the treatment. To identify
the potential inhibitors, we have performed molecular docking against the SARS-CoV-2 main
protease (6Y84) with fifteen important natural xanthone compounds. The docking results showed
all the compounds exhibited good binding energies and interactions with the main protease. The
validation of representative docking complexes through molecular dynamics simulations showed
that xanthones binds with a higher binding affinity and lower free energy than the standard
ligand with Brasixanthone C and Brasixanthone B on 50 ns. Natural xanthone compounds have
also passed the Absorption, Distribution, Metabolism, and Excretion (ADME) property criteria
as well as Lipinski’s rule of five. The present integrated molecular docking and dynamics
simulations study unveil the use of xanthones as potential antiviral agents against SARS-CoV-2.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
This is a list of supplementary files associated with this preprint. Click to download.
Loading...